Tuberculosis: The Disease That Changed World History Tuberculosis: The Disease That Changed World History
Scientific discoveries have greatly improved the prevention, diagnosis, and treatment of TB. Yet efforts to eradicate the disease appear to have taken a step backward.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - May 16, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure
Almost half of the world ’s population has no or limited access to diagnosticsThis situation is especially acute in low- and middle-income countries (LMICs) where diagnostics plays a critical role for treating and containing the spread of infectious diseases such as Tuberculosis (TB) and HIVNew partnership between Roche and the Global Fund supports low- and middle-income countries in broadening access to diagnostics, helping millions of previously undiagnosed people with TB and HIV get diagnosed and eventually treatedBasel, 12 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY), through its Global Access Program, and The Globa...
Source: Roche Media News - May 12, 2022 Category: Pharmaceuticals Source Type: news

Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure
Almost half of the world ’s population has no or limited access to diagnosticsThis situation is especially acute in low- and middle-income countries (LMICs) where diagnostics plays a critical role for treating and containing the spread of infectious diseases such as Tuberculosis (TB) and HIVNew partnership between Roche and the Global Fund supports low- and middle-income countries in broadening access to diagnostics, helping millions of previously undiagnosed people with TB and HIV get diagnosed and eventually treatedBasel, 12 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY), through its Global Access Program, and The Globa...
Source: Roche Investor Update - May 12, 2022 Category: Pharmaceuticals Source Type: news

South Africa: Fresh Air and Better Houses Are Weapons in the Fight Against TB
[GroundUp] The disease has been rare in rich countries for 50 years, and one reason is decent housing (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - May 10, 2022 Category: Infectious Diseases Source Type: news

South Africa: This Vaccine Could Save Tens of Thousands of South African Lives Each Year, but We'll Only See It in 2030
[GroundUp] Vaccines against TB are much slower to develop than Covid ones (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - May 9, 2022 Category: Infectious Diseases Source Type: news

Africa: WHO Launches a Second Report of Country Success Stories in Mitigating the Impact of the Covid-19 Pandemic On TB Services
[WHO] The World Health Organization (WHO) Global TB Programme is pleased to share its second report of country success stories in mitigating the impact of the COVID-19 pandemic on TB services. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - May 9, 2022 Category: Infectious Diseases Source Type: news

Africa: WHO Issues Rapid Communication On Updated Guidance for the Treatment of Drug-Resistant Tuberculosis
[WHO] A rapid communication released by the World Health Organization (WHO) Global Tuberculosis Programme has announced upcoming updates to the guidance on the treatment of drug-resistant tuberculosis (DR-TB). These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - May 9, 2022 Category: Infectious Diseases Source Type: news

Africa: Drug-Resistant Tuberculosis Trial Results in Updated Treatment Guidelines
[MSF] Geneva -- The World Health Organization (WHO) has announced it will update global guidance on treatment of multidrug-resistant tuberculosis (MDR-TB), following the results shared from the TB PRACTECAL trial. The clinical trial from M édecins Sans Frontières (MSF) has found a new, safer and more effective six-month oral treatment regimen for MDR-TB. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - May 6, 2022 Category: Infectious Diseases Source Type: news

Decrease in Tuberculosis Cases During COVID-19 Pandemic Decrease in Tuberculosis Cases During COVID-19 Pandemic
An analysis of prescription data noted a significant decline in reported tuberculosis cases during the COVID-19 pandemic. What factors may account for the downward trend?Emerging Infectious Diseases (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - May 4, 2022 Category: Infectious Diseases Tags: Infectious Diseases Journal Article Source Type: news

Nail in the Coffin for Injectable Therapy in Drug-Resistant TB?
(MedPage Today) -- Oral treatment containing bedaquiline was associated with better outcomes for patients with drug-resistant tuberculosis (TB) compared with an injectable treatment regimen, a retrospective cohort study showed. In adjusted analyses... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - May 4, 2022 Category: Infectious Diseases Source Type: news

Somalia: Healing From Drug-Resistant Tuberculosis in Somaliland
[MSF] Tuberculosis (TB) is a major public health concern in Somalia, where an increase in cases year over year is causing a high death rate and disease burden. Limited awareness of the disease, long distances to health facilities and the use of traditional healers contribute to the prevalence of TB. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - May 3, 2022 Category: Infectious Diseases Source Type: news

Covid-19 Has Made Tuberculosis Even More Of A Forgotten Pandemic
The impact of the Covid-19 pandemic goes well beyond the disease itself. It extends to neglected tropical diseases, as well as the big three infectious diseases malaria, HIV/AIDS, and tuberculosis, by crowding out R&D funds and disrupting non-Covid-19 related healthcare services. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 3, 2022 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

Pacific Community-Led Health Missions Arrive with Critical Support to Tonga and Kiribati Grappling with COVID-19 Surges
Pacific Community health experts conduct laboratory training for COVID-19 testing with their healthcare colleagues in Nuku'alofa, Tonga. Credit: Pacific Community (SPC)By Catherine WilsonCANBERRA, Australia , May 3 2022 (IPS) Before the pandemic emerged in 2020, health services in many Pacific Island countries were under-resourced, under-funded and under-staffed. Now following recent outbreaks of COVID-19, advancing the capacity and development of health and medical services in vulnerable nations, such as Tonga and Kiribati, is increasingly urgent. In the central Pacific atoll nation of Kiribati, virus cases have skyrocke...
Source: IPS Inter Press Service - Health - May 3, 2022 Category: International Medicine & Public Health Authors: Catherine Wilson Tags: Asia-Pacific COVID-19 Development & Aid Editors' Choice Featured Headlines Health Humanitarian Emergencies PACIFIC COMMUNITY Pacific Community Climate Wire TerraViva United Nations #AsiaPacific #Covid19 IPS UN Bureau IPS UN Bur Source Type: news

Global rollout of rapid molecular tests for tuberculosis over the last 12 years: Cochrane Review summarizes research on recipient and provider views
A potential game-changer in the tuberculosis epidemic was how the tuberculosis community viewed rapid molecular tests for tuberculosis and tuberculosis drug resistance. This was 12 years ago, with the launch of Xpert MTB/RIF, which gives results in less than two hours, simultaneously diagnosing tuberculosis and testing if the bacteria have rifampicin resistance, a type of drug-resistant tuberculosis. Multidrug-resistant tuberculosis is caused by resistance to at least both rifampicin and isoniazid, the two most effective first-line drugs used to treat tuberculosis.  Yet, diagnostic tests only have an impact on health if t...
Source: Cochrane News and Events - May 2, 2022 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Washington Having Largest Tuberculosis Outbreak In 20 Years
The Covid-19 coronavirus pandemic may have delayed screening and diagnosis of tuberculosis (TB) cases, allowing Mycobacterium tuberculosis to spread further. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 1, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news